{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "87441-013",
      "generic_name": "ATORVASTATIN CALCIUM",
      "labeler_name": "Unit Dose Solutions, Inc.",
      "brand_name": "ATORVASTATIN CALCIUM",
      "active_ingredients": [
        {
          "name": "ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE",
          "strength": "40 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "87441-013-01",
          "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (87441-013-01)",
          "marketing_start_date": "20260608",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Unit Dose Solutions, Inc."
        ],
        "rxcui": [
          "617311"
        ],
        "spl_set_id": [
          "53c06fa9-ec26-5fa6-e063-6294a90a337f"
        ],
        "unii": [
          "YRZ789OWMI"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "53c08333-038a-1575-e063-6394a90a233c",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260608",
      "product_id": "87441-013_53c08333-038a-1575-e063-6394a90a233c",
      "application_number": "ANDA090548",
      "brand_name_base": "ATORVASTATIN CALCIUM",
      "pharm_class": [
        "HMG-CoA Reductase Inhibitor [EPC]",
        "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"
      ]
    }
  ]
}